Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oncolytics Biotech Inc 804 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 CAN

www.oncolyticsbiotech.com Employees: 28 P: 403-670-7380 F: 403-283-0858

Sector:

Medical

Description:

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Key Statistics

Overview:

Market Capitalization, $K 107,207
Enterprise Value, $K 95,577
Shares Outstanding, K 106,146
Float, K 106,040
% Float 99.90%
Short Interest, K 3,551
Short Float 3.54%
Days to Cover 5.30
Short Volume Ratio 0.33
% of Insider Shareholders 0.10%
% of Institutional Shareholders 6.82%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -23,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,450 K
EBIT, $ -25,070 K
EBITDA, $ -24,760 K

Growth:

1-Year Return 20.45%
3-Year Return -47.12%
5-Year Return -60.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 57.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/12/25
Next Earnings Date 03/06/26
Earnings Per Share ttm -0.28
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -11.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 2-19 on 05/25/18

ONCY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -756.39%
Return-on-Assets % -187.94%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -1.37
60-Month Beta 0.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar